Exhibit 4.22
ab
Additional Tier 1 capital (Basel III-compliant)
Issuer UBS Group AG, or other employing entities of the UBS group
ISIN -
Issue Date 21.02.20211
Currency USD
Nominal 2
(million)
Coupon Rate 4% / 2.6%3
Maturity Date perpetual4
First Call Date 1 March 20265
1 Issuance
date which corresponds to grant date for employees.
2 Nominal amount at issuance with respective exchange rate used. For
information on the outstanding amount, refer to the table “Capital and total
loss-absorbing capacity instruments of UBS Group AG consolidated and UBS AG
consolidated and standalone - Key features”.
3 Applicable to USD-denominated and CHF-denominated issues,
respectively and not payable to EU/UKMRTs and SMFs, both as defined within this
document.
4 Subject to forfeiture and vesting provisions.
5 For SMFs and certain EU MRT, as defined within this document,
partly also 1 March 2027 and 1 March 2028.
Deferred Contingent Capital Plan 2020/21 (DCCP)
Summary description of the terms and conditions of DCCP as a capital instrument
|
Overview |
Issues under the DCCP are made by UBS Group AG or certain other employing entities to key contributors at UBS Group AG or any of its subsidiaries (together, the "Group"). Eligibility is determined by the Issuer and issues are granted at its sole discretion. |
|
Issuer |
UBS Group AG or certain other employing entities of the UBS group
|
|
Type of instrument |
Non-transferable contingent right against the Issuer to receive (i) discretionary annual interest equivalent payments on the nominal value of a hypothetical perpetual Additional Tier 1 ("AT1") security notionally issued by UBS Group AG at grant (the "Notional Bond"), and (ii) at redemption, as determined by the Issuer in its sole discretion, either the value of the Notional Bond in cash or perpetual AT1 securities issued or guaranteed by UBS Group AG or any other member of the Group of equivalent value (in each case net of any applicable taxes and social security contributions to the employee's account).
For DCCP awarded to EU/UK Material Risk Takers (MRT)[1] and individuals performing designated Senior Management Functions (SMF)[2] there will be no contingent right to receive discretionary annual interest payments; only non-transferable contingent right against the Issuer to receive the amount indicated under (ii) above.
|
|
Conditional Interest Equivalents |
Subject to (i) the conditions set out under "Trigger Event or Viability Event" and "Forfeiture and Vesting Provisions" and (ii) the discretionary and mandatory interest cancellation provisions as set out below, interest equivalents will be payable annually in arrears on the nominal value of the Notional Bond at a rate of 2.6% for CHF-denominated issues and 4% for USD-denominated issues.
The Issuer may, at its discretion, elect to cancel any interest equivalent that is otherwise scheduled to be paid on any interest payment date. In addition, without limitation to the foregoing, payments of interest equivalents will not be made unless sufficient distributable items (i.e., net profits carried forward and freely distributable reserves) of UBS Group AG are available.
|
|
Maturity date |
Issues under the DCCP have no scheduled maturity date.
Notwithstanding the foregoing, but subject to the conditions set out under "Trigger Event or Viability Event" and "Forfeiture and Vesting Provisions", issues to US taxpayers will mature and be settled on or about 1 March 2026 (the "First Call Date"). The Notional Bond underlying such issues will have no scheduled maturity date.
|
[1] Based on relevant European Banking Authority's ("EBA") Regulatory Technical Standards (RTS) for EU MRTs, and for UK MRTs, based on the EBA RTS and the UK Prudential Regulation Authority's and Financial Conduct Authority's rules.
[2] As defined by the UK’s Prudential Regulation Authority and Financial Conduct Authority.